Published in Int J Clin Exp Pathol on June 16, 2009
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med (2005) 26.02
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A (2005) 21.51
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med (2003) 6.82
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med (2001) 5.66
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest (2007) 5.02
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood (1998) 4.07
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood (2002) 3.17
Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood (2004) 2.71
B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol (1999) 2.60
ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood (2004) 2.30
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood (2001) 2.14
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood (2003) 1.99
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood (2002) 1.94
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood (2002) 1.85
CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia (2005) 1.70
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood (2007) 1.69
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood (2004) 1.63
Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood (2001) 1.55
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia (2005) 1.47
Role of the microenvironment in chronic lymphocytic leukaemia. Br J Haematol (2003) 1.44
The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood (2002) 1.44
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology (2005) 1.41
CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood (1996) 1.35
Some issues in resolution of diagnostic tests using an imperfect gold standard. Stat Med (2001) 1.24
Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood (1992) 1.11
The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol (2006) 1.02
Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood (2002) 1.00
Bcl-2 and apoptosis in chronic lymphocytic leukemia. Curr Treat Options Oncol (2003) 1.00
Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin. Leukemia (2007) 0.98
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol (1996) 0.96
New views of BCR structure and organization. Curr Opin Immunol (2001) 0.95
Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood (1996) 0.89
Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation. Leukemia (2004) 0.89
Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells. Leukemia (2005) 0.89
Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. Appl Immunohistochem Mol Morphol (2000) 0.88
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol (2002) 0.88
Role of the human CD38 molecule in B cell activation and proliferation. Tissue Antigens (1997) 0.87
bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow. Am J Clin Pathol (2003) 0.86
Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia. Semin Hematol (2004) 0.85
Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia. Cytometry B Clin Cytom (2005) 0.81
Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells. Biochem Biophys Res Commun (2004) 0.80
Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro. Eur J Haematol (1996) 0.78
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood (2011) 7.43
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer (2009) 2.78
Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res (2010) 2.00
Atypical cellular disorders. Hematology Am Soc Hematol Educ Program (2004) 1.70
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom (2010) 1.61
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies. Am J Clin Pathol (2004) 1.44
Lymph node grading for staging of mycosis fungoides may benefit from examination of multiple excised lymph nodes. J Am Acad Dermatol (2003) 1.38
Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer (2003) 1.35
Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol (2005) 1.31
Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol (2012) 1.25
Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol (2002) 1.24
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica (2011) 1.22
Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol (2003) 1.18
Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma. Clin Cancer Res (2008) 1.13
Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica (2011) 1.10
Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders. Diagn Mol Pathol (2007) 1.10
Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer (2008) 1.07
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood (2013) 1.06
Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Am J Surg Pathol (2007) 1.04
Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol (2011) 1.03
The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol (2006) 1.02
Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol (2009) 0.99
Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation. Am J Clin Pathol (2011) 0.99
Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Am J Surg Pathol (2013) 0.98
Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol (2013) 0.96
Classical Hodgkin's lymphoma presenting as a testicular mass: report of a case. Int J Surg Pathol (2007) 0.96
Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Am J Surg Pathol (2006) 0.95
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood (2013) 0.94
EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder? Am J Surg Pathol (2011) 0.94
Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV. Diagn Mol Pathol (2003) 0.93
Follicular lymphoma of the spleen: multiparameter analysis of 16 cases. Am J Clin Pathol (2009) 0.92
Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol (2004) 0.92
Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas. Am J Surg Pathol (2005) 0.91
CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol (2009) 0.91
Mycosis fungoides: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol (2013) 0.90
Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod Pathol (2008) 0.90
Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases. Am J Surg Pathol (2012) 0.90
Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol (2012) 0.89
Splenic marginal zone lymphomas appear to originate from different B cell types. Am J Pathol (2002) 0.89
Abnormal patterns of antigenic expression in follicular lymphoma: a flow cytometric study. Am J Clin Pathol (2005) 0.88
Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry. Am J Clin Pathol (2002) 0.88
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component. Am J Surg Pathol (2011) 0.87
Inter- and intra-observer reliability of Epstein-Barr virus detection in Hodgkin lymphoma using histochemical procedures. Leuk Lymphoma (2004) 0.86
bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow. Am J Clin Pathol (2003) 0.86
Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease. Am J Surg Pathol (2014) 0.85
Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas. Mod Pathol (2003) 0.85
Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma. Am J Surg Pathol (2008) 0.84
Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am J Surg Pathol (2010) 0.84
TIM3 expression by leukemic and non-leukemic myeloblasts. Cytometry B Clin Cytom (2013) 0.84
Best practices in contemporary diagnostic immunohistochemistry: panel approach to hematolymphoid proliferations. Arch Pathol Lab Med (2009) 0.83
Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. Mod Pathol (2004) 0.83
t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas. J Cutan Pathol (2006) 0.83
Pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue associated with granulomatous inflammation in a child with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome). J Pediatr (2012) 0.83
Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy. Dig Dis Sci (2006) 0.82
Primary and secondary cutaneous diffuse large B-cell lymphomas: a multiparameter analysis of 25 cases including fluorescence in situ hybridization for t(14;18) translocation. Am J Surg Pathol (2003) 0.82
MALT Lymphoma in Children: Case Report and Review of the Literature. Pediatr Dev Pathol (2004) 0.82
Splenic small B-cell lymphoma with IGH/BCL3 translocation. Hum Pathol (2006) 0.82
Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate. Clin Rheumatol (2006) 0.81
Mucosa-associated lymphoid tissue lymphoma of the cervix. J Clin Oncol (2008) 0.81
Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa. Mod Pathol (2009) 0.81
Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study. Hum Pathol (2012) 0.81
Intestinal γδ T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type. Hum Pathol (2013) 0.81
Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens. Am J Clin Pathol (2008) 0.81
Defining the borders of splenic marginal zone lymphoma: a multiparameter study. Hum Pathol (2009) 0.81
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements. Am J Surg Pathol (2016) 0.81
Whole-genome single nucleotide polymorphism array analysis is complementary to classical cytogenetic analysis in the evaluation of lymphoid proliferations. Am J Clin Pathol (2014) 0.80
Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies. J Reprod Med (2010) 0.80
Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma. Mod Pathol (2008) 0.80
Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality. J Cutan Pathol (2011) 0.80
T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumor. Hum Pathol (2002) 0.79
Flow cytometric immunophenotyping of cerebrospinal fluid specimens. Am J Clin Pathol (2011) 0.79
JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses. Am J Clin Pathol (2007) 0.78
Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma. Cancer Genet Cytogenet (2007) 0.78
Analysis of immunoglobulin V genes suggests cutaneous marginal zone B-cell lymphomas recognise similar antigens. Br J Haematol (2006) 0.78
Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. The Ad Hoc Committee on reporting of lymphoid neoplasms. Hum Pathol (2002) 0.77
Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma. Cancer Genet Cytogenet (2005) 0.77
Classical nodular sclerosis Hodgkin lymphoma presenting with central nervous system disease. South Med J (2007) 0.77
Expression of S100 Protein in CD4-positive T-cell Lymphomas Is Often Associated With T-cell Prolymphocytic Leukemia. Am J Surg Pathol (2015) 0.77
Plasma cell (Zoon) balanitis: another inflammatory disorder that can be rich in IgG4+ plasma cells. Am J Surg Pathol (2014) 0.77
Altered neutrophil maturation patterns that limit identification of myelodysplastic syndromes. Cytometry B Clin Cytom (2012) 0.76
Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression. Am J Clin Pathol (2012) 0.76
The number and growth pattern of plasmacytoid dendritic cells vary in different types of reactive lymph nodes: an immunohistochemical study. Hum Pathol (2012) 0.76
Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features. Hum Pathol (2011) 0.75
Peritoneal tuberculosis in an immunocompetent, unknown risk patient. Case Rep Gastrointest Med (2013) 0.75
Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas. Mod Pathol (2012) 0.75
Nodal aggressive B-cell lymphomas: a diagnostic approach. J Clin Pathol (2007) 0.75
Robert Deaver Collins (1928-2013): a life dedicated to teaching, investigation, and concern for human beings and our earth. Am J Surg Pathol (2014) 0.75
Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold. Cytometry B Clin Cytom (2013) 0.75
T(14;18)(q32;q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma. Hum Pathol (2003) 0.75
Splenic lymphoid subsets with less well-recognized phenotypes mimic aberrant antigen expression. Am J Clin Pathol (2013) 0.75
ZAP-70 and Bcl-2 expression in B lymphoblastic leukemia cells and hematogones. Cytometry B Clin Cytom (2011) 0.75